Trustees of Columbia University in the City of New York’s Tenaya Therapeutics TNYA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-291,828
Closed -$473K 7
2025
Q3
$473K Hold
291,828
0.07% 3
2025
Q2
$178K Hold
291,828
0.03% 6
2025
Q1
$166K Hold
291,828
0.03% 7
2024
Q4
$417K Buy
+291,828
New +$654K 0.07% 6
2023
Q4
$946K Hold
291,828
2% 3
2023
Q3
$744K Hold
291,828
1.37% 6
2023
Q2
$1.71M Hold
291,828
2.51% 6
2023
Q1
$832K Hold
291,828
1.49% 8
2022
Q4
$587K Buy
+291,828
New +$712K 1.21% 9
2021
Q3
$6.03M Buy
+291,828
New +$6.27M 9.22% 3

Other funds holding TNYA

Trustees of Columbia University in the City of New York's TNYA Position: Q4 2025 in Review

Trustees of Columbia University in the City of New York sold out of Tenaya Therapeutics (TNYA) in Q4 2025, closing a stake of 291,828 shares — an estimated $473K sold.

Trustees of Columbia University in the City of New York first reported a position in TNYA in Q3 2021 and held it in 10 quarters. The position peaked at $6.03M in Q3 2021. 97 funds tracked by Wall St. Rank hold TNYA as of Q4 2025.

  • Trustees of Columbia University in the City of New York reported no remaining Tenaya Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Trustees of Columbia University in the City of New York sold 291,828 Tenaya Therapeutics shares in Q4 2025, an estimated $473K.
  • Trustees of Columbia University in the City of New York first reported a position in Tenaya Therapeutics in Q3 2021 and held it in 10 quarters.
  • Trustees of Columbia University in the City of New York's Tenaya Therapeutics position peaked at $6.03M in Q3 2021.
  • 97 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q4 2025.

Based on Trustees of Columbia University in the City of New York's 13F filing for Q4 2025, filed 13 Feb 2026.